Al-Hassany, Linda
Karsan, Nazia
Lampl, Christian
Goadsby, Peter J.
MaassenVanDenBrink, Antoinette
Funding for this research was provided by:
Dutch Research Council (Vici Grant 09150181910040)
Article History
Received: 8 May 2023
Accepted: 25 May 2023
First Online: 9 June 2023
Declarations
:
: Not applicable. No additional approval from the Ethics Board was required.
: Written informed consent was obtained from the patient for publication of the current case report.
: Linda Al-Hassany and Nazia Karsan declare no conflict of interest with respect to the research, authorship, and/or publication of this article.Christian Lampl reports consultation fees from Allergan/Abbvie, Eli Lilly, Lundbeck, Novartis, Pfizer and Teva.Peter J Goadsby reports, over the last 36 months, a grant from Celgene, and personal fees from Aeon Biopharma, Allergan/Abbvie, Amgen, Biodelivery Sciences International, Biohaven Pharmaceuticals Inc., CoolTech LLC, Dr Reddys, Eli-Lilly, Epalex, GlaxoSmithKline, Impel Neuropharma, Lundbeck, Novartis, Praxis, Sanofi, Satsuma and Teva Pharmaceuticals, and personal fees for advice through Gerson Lehrman Group, Guidepoint, SAI Med Partners, Vector Metric, and fees for educational materials from CME Outfitters, Omnia Education, WebMD, and publishing royalties or fees from Massachusetts Medical Society, Oxford University Press, UptoDate and Wolters Kluwer, and for medicolegal advice in headache, and a patent magnetic stimulation for headache (No. WO2016090333 A1) assigned to eNeura without fee.Antoinette MaassenVanDenBrink received research grants and/or consultation fees from Allergan, Amgen/Novartis, Eli Lilly, Satsuma, Teva, Tonix, and ATI.